2.5mg of BAT5906

DRUG2 trials

Sponsors

Bio-Thera Solutions

Conditions

Diabetic Macular EdemaWet Age-related Macular Degeneration

Phase 1

Study of Two Multiple Intravitreal Doses of BAT5906 for Safety and Efficacy in Patients With Diabetic Macular Edema

CompletedNCT04772105

Bio-Thera SolutionsDiabetic Macular Edema

Start: 2020-10-16End: 2023-11-06Updated: 2026-07-14

Phase 2

Clinical Study on the Efficacy and Safety of BAT5906 Injection

CompletedNCT05141994

Bio-Thera SolutionsWet Age-related Macular Degeneration

Start: 2020-08-26End: 2022-09-06Updated: 2024-04-16